In the article on TRAIL gene therapy for lung cancer in the March 1, 2005, issue of Cancer Research (1), Dr. Dexian Zheng should have been listed as a co-corresponding author: Dexian Zheng, National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, 5 Dong Dan San Tiao, Beijing 100005, China. Phone: 8610-6529-6409; Fax: 8610-6510-5102; E-mail: [email protected].

Shi J, Zheng D, Liu Y, et al. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.
Cancer Res